At its meeting of 24 June 2010 the Supervisory Board of Carl Zeiss AG passed a unanimous resolution concerning personnel changes in the Executive Board. As planned, President and CEO of Carl Zeiss AG, Dr. Dieter Kurz, will not renew his contract that is due to expire at the end of 2010. Dr. Michael Kaschke, Member of the Carl Zeiss Executive Board, was appointed as the new President and CEO, effective 1 January 2011.

Thomas Spitzenpfeil, currently CFO at Zumtobel AG, has been appointed as a new Member of the Executive Board effective 1 October 2010. In his role as CFO he will be responsible, among other things, for the company's finances in the future. Together with Dr. Hermann Gerlinger, who has been a Member of the Executive Board since 2006, Dr. Michael Kaschke and Thomas Spitzenpfeil will constitute the Executive Board of Carl Zeiss AG from 2011.

The Supervisory Board considers that Dr. Michael Kaschke is the ideal person to succeed Dr. Dieter Kurz. "This has been repeatedly demonstrated by Dr. Kaschke in his functions at Carl Zeiss and during his ten years as a Member of the Executive Board,"
Dr. Spettmann continued. "He acquired his many years of experience in the international arena during, for example, the expansion of Carl Zeiss activities in Asia, particularly in India and China. With his in-depth understanding of innovation and strategic business development, he has successfully driven forward the Microscopy and Medical Systems Groups. His stringent and holistic financial management of individual business groups and the entire Carl Zeiss Group has made a major contribution to the Group's outstanding balance sheet."

As a new Member of the Executive Board, Thomas Spitzenpfeil will assume the position of CFO in the future. Dr. Spettmann said: "We are pleased that, with Thomas Spitzenpfeil, we have obtained an internationally experienced manager and financial expert for this position. I firmly believe that Carl Zeiss will remain on track to sustained value enhancement in the future."